Plastic exposure may be far more changeable from one day to the next than a single urine sample can reveal, according to a new biomonitoring study from Korea. In a seven-day consecutive sampling case study, researchers examined how repeated biological measurements can improve exposure assessment for phthalates and newer non-phthalate plasticizers—chemicals widely used to make plastics flexible, durable, and easier to process. The work, published in the Journal of Exposure Science & Environmental Epidemiology, focuses less on identifying one dramatic source of exposure than on a problem that has quietly challenged environmental health researchers for years: how to measure an individual’s real-world contact with plasticizer chemicals when exposure is continuous, variable, and difficult to reconstruct. The study’s central message is methodological but potentially far-reaching. Sampling someone once may provide only a snapshot, while consecutive samples can reveal the rhythm of exposure across ordinary daily life.
Phthalates have been used in products ranging from food packaging and flooring to cosmetics, medical equipment, household materials, and personal-care products. Because many phthalates are not chemically bound to the plastic matrix, they can gradually migrate into air, dust, food, beverages, and consumer products. People may then ingest, inhale, or absorb them through the skin. Concern has grown because several phthalates or their metabolites have been associated in previous research with endocrine disruption, reproductive and developmental effects, altered metabolism, and other health outcomes. In response, manufacturers and regulators have increasingly turned to alternative plasticizers, including compounds marketed as substitutes for restricted phthalates. But replacing a chemical does not automatically eliminate uncertainty. Non-phthalate plasticizers may have different chemical structures and biological behaviors, and many have been used widely before researchers fully understood how they move through the human body.
That is why biomonitoring is so important. Instead of estimating exposure only from questionnaires, product inventories, or environmental measurements, biomonitoring measures chemicals or their metabolites directly in biological specimens. For plasticizers, urine is especially useful because the body commonly transforms these compounds into metabolites that are subsequently excreted. Laboratory analysis can detect these breakdown products at very low concentrations, offering a more integrated picture of exposure from multiple pathways. However, urinary biomarkers also create a timing challenge. Some metabolites are eliminated relatively quickly, meaning that a sample may primarily reflect exposure during the previous several hours or day. Others may behave differently depending on metabolism, hydration, kidney function, and the chemical itself. A single measurement can therefore miss short-lived peaks or exaggerate the importance of an unusual event, such as eating a particular meal or using a specific personal-care product.
The Korean case study addresses that problem by following participants through seven consecutive days rather than relying on one isolated collection. Repeated sampling allows researchers to distinguish persistent exposure from day-to-day fluctuation. If a biomarker appears at a similar level across the week, that pattern may suggest relatively stable sources or regular behaviors. If concentrations rise and fall sharply, the variation may point to episodic contact, changing diets, household activities, workplace conditions, or the rapid clearance of the chemical from the body. Consecutive sampling also helps estimate within-person variability—the changes occurring in the same individual over time—and between-person variability, the differences observed among individuals. This distinction is essential for epidemiological studies, because the number of samples needed to characterize exposure depends heavily on how much concentrations fluctuate within each person.
The study also highlights why measuring both established phthalates and non-phthalate alternatives matters. Chemical substitution can alter the exposure landscape without necessarily reducing it. A population might show declining levels of one restricted phthalate while simultaneously experiencing widespread exposure to replacement compounds. Yet the two groups cannot always be interpreted in exactly the same way. Their metabolites may have different half-lives, may be produced in different proportions, and may require different laboratory methods or correction strategies. A reliable monitoring program must therefore account for the specific pharmacokinetics of each compound. Researchers need to know how quickly a parent chemical is absorbed and transformed, which metabolites are most informative, how long those metabolites remain detectable, and whether a measured concentration reflects a recent event or a more sustained exposure pattern.
Repeated urine collection is not as simple as asking participants to provide more samples. Hydration can dilute or concentrate urine, making raw concentrations difficult to compare. Investigators may correct for dilution using creatinine, specific gravity, or other approaches, but each method has assumptions and limitations. Creatinine-based correction, for example, can vary with muscle mass, age, sex, diet, and health status. Specific gravity is also influenced by factors affecting urine density. Timing matters as well: first-morning urine, spot samples taken during the day, and complete 24-hour collections can produce different kinds of information. The value of a seven-day design therefore depends not only on the number of specimens but also on consistent collection procedures, accurate recording of sampling times, careful storage, and analytical methods capable of distinguishing closely related metabolites from contamination.
Contamination is a particularly serious concern in plasticizer research because the chemicals being measured may be present in collection materials, laboratory equipment, tubing, gloves, packaging, or the surrounding environment. A study can produce apparently precise results while still being vulnerable to background contamination if blanks, controls, and handling protocols are inadequate. Methodological studies such as the Korean investigation are valuable because they draw attention to the full chain of measurement, from participant instructions to sample transport and instrumental analysis. High-resolution analytical techniques, including chromatography coupled with mass spectrometry, can separate and identify compounds based on their chemical properties and mass-to-charge signatures. But sophisticated instruments cannot compensate for poor sampling design. The credibility of biomonitoring depends on both analytical sensitivity and exposure-aware field procedures.
The seven-day approach also has implications for how future health studies are designed. If exposure is highly variable, researchers may need multiple specimens per participant to reduce misclassification—the error that occurs when a person is labeled as having low or high exposure based on a measurement that does not represent their usual level. Misclassification can weaken apparent links between chemical exposure and disease, sometimes making a genuine association appear smaller or disappear entirely. Repeated measurements can improve estimates of typical exposure and may help investigators identify short-term peaks that are relevant to biological responses. At the same time, more intensive sampling increases cost, participant burden, and the possibility that volunteers change their behavior because they know they are being observed. The challenge is to find a sampling schedule that is scientifically informative without becoming unrealistic for large populations.
The findings are especially relevant in Korea and across rapidly industrializing societies where modern consumers encounter complex mixtures of plasticizers through food systems, indoor environments, consumer goods, and occupational settings. They also offer a warning against treating “phthalate-free” or “alternative plasticizer” labels as the end of the exposure story. A product may contain a substitute chemical with a different hazard profile, and the public may have little information about how extensively that substance has been evaluated. Biomonitoring cannot by itself prove that a particular product caused an individual’s exposure or that a measured concentration will produce illness. It can, however, reveal whether chemicals are entering the body, how consistently they do so, and which substances deserve closer toxicological and regulatory scrutiny. That evidence can guide product testing, exposure reduction, and population surveillance.
The broader significance of the study lies in its insistence that exposure assessment must follow the biology of the chemicals rather than the convenience of a one-time appointment. A single sample remains useful for large surveys, but consecutive sampling can expose patterns that would otherwise remain invisible: transient peaks, recurring daily exposures, and major differences in how individuals process and eliminate plasticizers. As non-phthalate alternatives continue to spread through the marketplace, researchers will need monitoring strategies capable of tracking chemical substitutions in real time. The Korean seven-day case study provides a practical model for that effort, showing how a carefully structured sampling window can turn an ambiguous snapshot into a more dynamic portrait of everyday chemical exposure. In a world where plastics are nearly impossible to avoid, understanding when and how those chemicals enter the body may be the first step toward reducing the risks that come with them.
Subject of Research: Biomonitoring-based exposure assessment of phthalate and non-phthalate plasticizers through seven-day consecutive sampling in Korea.
Article Title: Biomonitoring-based exposure assessment of phthalate and non-phthalate plasticizers: methodological insights from a 7-day consecutive sampling case study in Korea.
Article References: Kwon, J., Heo, JY., Lee, A. et al. “Biomonitoring-based exposure assessment of phthalate and non-phthalate plasticizers: methodological insights from a 7-day consecutive sampling case study in Korea.” Journal of Exposure Science & Environmental Epidemiology (2026). https://doi.org/10.1038/s41370-026-00963-7
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41370-026-00963-7
Keywords: phthalates, non-phthalate plasticizers, biomonitoring, urinary biomarkers, exposure assessment, consecutive sampling, environmental health, Korea, chemical exposure, plastic pollution
Tags: biomonitoring of plasticizer exposurechallenges in measuring plastic chemical contactenvironmental epidemiology of plasticizershealth risk assessment of plastic chemicalsimpact of daily life on chemical exposuremethodology for environmental chemical measurementplasticizer migration from productsreal-world plasticizer exposure assessmentrepeated urine sampling for phthalatesseven-day chemical exposure assessmenttracking non-phthalate plasticizer exposurevariability in plastic chemical contact
